[State Food and Drug Administration: Focus on cultivating 3 to 5 internationally competitive biopharmaceutical industry clusters] September 20, Yang Sheng, deputy director of the State Food and Drug Administration, said at a press conference held by the State Council Information Office on September 20 that good medicines must not only rely on high-level research and development, but also high-quality manufacturing. The State Food and Drug Administration will support the large-scale, intensive, and high-end development of the pharmaceutical industry and encourage pharmaceutical companies to build smart factories and green factories. We will continue to support the innovative development of the pharmaceutical industry in the Beijing-Tianjin-Hebei region, the Yangtze River Delta, the Guangdong-Hong Kong-Macao Greater Bay Area, the Chengdu-Chongqing economic circle and other regions, and strive to cultivate 3 to 5 internationally competitive biopharmaceutical industry clusters. We will support the expansion of opening-up and cooperation in the pharmaceutical field, encourage foreign investment to introduce original research drugs and high-end medical equipment for domestic production, and also encourage Chinese enterprises to "go out" for development, so that Chinese pharmaceuticals and equipment can benefit the world.